All of those 15,000 had previously signed up for gene-testing by the company 23andMe, which used that data to chart the experiences of people taking weight-loss drugs. By analysing millions of their genetic variants, the researchers found a pattern suggesting a link between some variants and the effectiveness of the drugs.